Cargando…

Chronic disease management: a qualitative study investigating the barriers, facilitators and incentives perceived by Swiss healthcare stakeholders

BACKGROUND: Chronic disease management has been implemented for some time in several countries to tackle the increasing burden of chronic diseases. While Switzerland faces the same challenge, such initiatives have only emerged recently in this country. The aim of this study is to assess their feasib...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauvergeon, Stéphanie, Burnand, Bernard, Peytremann-Bridevaux, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483191/
https://www.ncbi.nlm.nih.gov/pubmed/22726820
http://dx.doi.org/10.1186/1472-6963-12-176
_version_ 1782247961145638912
author Lauvergeon, Stéphanie
Burnand, Bernard
Peytremann-Bridevaux, Isabelle
author_facet Lauvergeon, Stéphanie
Burnand, Bernard
Peytremann-Bridevaux, Isabelle
author_sort Lauvergeon, Stéphanie
collection PubMed
description BACKGROUND: Chronic disease management has been implemented for some time in several countries to tackle the increasing burden of chronic diseases. While Switzerland faces the same challenge, such initiatives have only emerged recently in this country. The aim of this study is to assess their feasibility, in terms of barriers, facilitators and incentives to participation. METHODS: To meet our aim, we used qualitative methods involving the collection of opinions of various healthcare stakeholders, by means of 5 focus groups and 33 individual interviews. All the data were recorded and transcribed verbatim. Thematic analysis was then performed and five levels were determined to categorize the data: political, financial, organisational/ structural, professionals and patients. RESULTS: Our results show that, at each level, stakeholders share common opinions towards the feasibility of chronic disease management in Switzerland. They mainly mention barriers linked to the federalist political organization as well as to financing such programs. They also envision difficulties to motivate both patients and healthcare professionals to participate. Nevertheless, their favourable attitudes towards chronic disease management as well as the fact that they are convinced that Switzerland possesses all the resources (financial, structural and human) to develop such programs constitute important facilitators. The implementation of quality and financial incentives could also foster the participation of the actors. CONCLUSIONS: Even if healthcare stakeholders do not have the same role and interest regarding chronic diseases, they express similar opinions on the development of chronic disease management in Switzerland. Their overall positive attitude shows that it could be further implemented if political, financial and organisational barriers are overcome and if incentives are found to face the scepticism and non-motivation of some stakeholders.
format Online
Article
Text
id pubmed-3483191
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34831912012-10-30 Chronic disease management: a qualitative study investigating the barriers, facilitators and incentives perceived by Swiss healthcare stakeholders Lauvergeon, Stéphanie Burnand, Bernard Peytremann-Bridevaux, Isabelle BMC Health Serv Res Research Article BACKGROUND: Chronic disease management has been implemented for some time in several countries to tackle the increasing burden of chronic diseases. While Switzerland faces the same challenge, such initiatives have only emerged recently in this country. The aim of this study is to assess their feasibility, in terms of barriers, facilitators and incentives to participation. METHODS: To meet our aim, we used qualitative methods involving the collection of opinions of various healthcare stakeholders, by means of 5 focus groups and 33 individual interviews. All the data were recorded and transcribed verbatim. Thematic analysis was then performed and five levels were determined to categorize the data: political, financial, organisational/ structural, professionals and patients. RESULTS: Our results show that, at each level, stakeholders share common opinions towards the feasibility of chronic disease management in Switzerland. They mainly mention barriers linked to the federalist political organization as well as to financing such programs. They also envision difficulties to motivate both patients and healthcare professionals to participate. Nevertheless, their favourable attitudes towards chronic disease management as well as the fact that they are convinced that Switzerland possesses all the resources (financial, structural and human) to develop such programs constitute important facilitators. The implementation of quality and financial incentives could also foster the participation of the actors. CONCLUSIONS: Even if healthcare stakeholders do not have the same role and interest regarding chronic diseases, they express similar opinions on the development of chronic disease management in Switzerland. Their overall positive attitude shows that it could be further implemented if political, financial and organisational barriers are overcome and if incentives are found to face the scepticism and non-motivation of some stakeholders. BioMed Central 2012-06-22 /pmc/articles/PMC3483191/ /pubmed/22726820 http://dx.doi.org/10.1186/1472-6963-12-176 Text en Copyright ©2012 Lauvergeon et al.; http://creativecommons.org/licenses/by/2.0 licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lauvergeon, Stéphanie
Burnand, Bernard
Peytremann-Bridevaux, Isabelle
Chronic disease management: a qualitative study investigating the barriers, facilitators and incentives perceived by Swiss healthcare stakeholders
title Chronic disease management: a qualitative study investigating the barriers, facilitators and incentives perceived by Swiss healthcare stakeholders
title_full Chronic disease management: a qualitative study investigating the barriers, facilitators and incentives perceived by Swiss healthcare stakeholders
title_fullStr Chronic disease management: a qualitative study investigating the barriers, facilitators and incentives perceived by Swiss healthcare stakeholders
title_full_unstemmed Chronic disease management: a qualitative study investigating the barriers, facilitators and incentives perceived by Swiss healthcare stakeholders
title_short Chronic disease management: a qualitative study investigating the barriers, facilitators and incentives perceived by Swiss healthcare stakeholders
title_sort chronic disease management: a qualitative study investigating the barriers, facilitators and incentives perceived by swiss healthcare stakeholders
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483191/
https://www.ncbi.nlm.nih.gov/pubmed/22726820
http://dx.doi.org/10.1186/1472-6963-12-176
work_keys_str_mv AT lauvergeonstephanie chronicdiseasemanagementaqualitativestudyinvestigatingthebarriersfacilitatorsandincentivesperceivedbyswisshealthcarestakeholders
AT burnandbernard chronicdiseasemanagementaqualitativestudyinvestigatingthebarriersfacilitatorsandincentivesperceivedbyswisshealthcarestakeholders
AT peytremannbridevauxisabelle chronicdiseasemanagementaqualitativestudyinvestigatingthebarriersfacilitatorsandincentivesperceivedbyswisshealthcarestakeholders